Oral Microbiome Shows Distinct Patterns in Autism Spectrum Disorder
First systematic review reveals subtle but significant changes in oral bacteria composition and neurotransmitter pathways in individuals with autism.
Summary
This systematic review analyzed nine studies involving 8,533 participants to examine oral microbiome differences in autism spectrum disorder (ASD). While microbial diversity findings were inconsistent across studies, researchers identified significant alterations in metabolic pathways affecting dopamine and GABA degradation, plus disruptions in lysine metabolism. These changes suggest potential links between oral bacteria and neurotransmitter imbalances characteristic of ASD, though direct connections to clinical symptoms remain unclear.
Detailed Summary
This groundbreaking systematic review represents the first comprehensive analysis of oral microbiome composition in autism spectrum disorder (ASD), examining data from nine studies encompassing 8,533 participants (2,536 with ASD and 5,937 controls). The research addresses a critical gap in understanding how oral bacteria may influence neurological function through the emerging oral-gut-brain axis.
The study methodology involved comprehensive searches across multiple databases for peer-reviewed case-control and cross-sectional studies published between 2000-2025. Researchers used the Newcastle-Ottawa scale to assess study quality and followed PRISMA guidelines for systematic reviews.
Key findings revealed inconsistent patterns in overall microbial diversity, with some studies showing alterations in ASD while others found no significant differences. However, functional profiling uncovered more consistent patterns: enrichment of pathways involved in dopamine and GABA degradation, along with disruptions in lysine metabolism. These metabolic changes suggest potential mechanisms linking oral microbiome composition to neurotransmitter imbalances commonly observed in ASD.
The research explored various external factors that might influence oral microbiome composition, including selective eating patterns, oral hygiene practices, and cognitive function. While these factors were proposed as potential modulators, statistical evidence supporting direct associations remained lacking. Notably, no consistent relationships were established between oral microbiota features and core ASD symptoms like repetitive behaviors or communication deficits.
These findings have important implications for understanding ASD pathophysiology and developing personalized therapeutic approaches. The identification of specific metabolic pathway alterations opens new avenues for research into microbiome-targeted interventions. However, the inconsistent diversity findings and lack of direct symptom correlations highlight the need for larger, more standardized studies using multi-omics approaches and longitudinal designs to clarify the oral microbiome's role in ASD.
Key Findings
- Functional pathways showed enrichment in dopamine and GABA degradation in ASD patients
- Lysine metabolism disruptions were consistently observed across ASD participants
- Overall microbial diversity findings were inconsistent between studies
- No direct correlations found between oral microbiota and core ASD symptoms
- External factors like diet and oral hygiene lacked statistical evidence for microbiome influence
Methodology
Systematic review of nine case-control and cross-sectional studies using Newcastle-Ottawa quality assessment. Studies employed 16S rRNA sequencing and metagenomic analysis of saliva, dental plaque, and tongue samples from 8,533 total participants.
Study Limitations
Inconsistent microbial diversity findings across studies, lack of standardized methodologies, and absence of direct correlations with clinical symptoms limit clinical applications. Heterogeneous study designs prevented meta-analysis and quantitative synthesis.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.